186 related articles for article (PubMed ID: 19555306)
1. Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium.
Yin YM; Cui FD; Kim JS; Choi MK; Choi BC; Chung SJ; Shim CK; Kim DD
Drug Deliv; 2009 Jan; 16(1):30-6. PubMed ID: 19555306
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS).
Kadu PJ; Kushare SS; Thacker DD; Gattani SG
Pharm Dev Technol; 2011 Feb; 16(1):65-74. PubMed ID: 20088679
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
Shen H; Zhong M
J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
[TBL] [Abstract][Full Text] [Related]
5. Redispersible, dry emulsion of lovastatin protects against intestinal metabolism and improves bioavailability.
Ge Z; Zhang XX; Gan L; Gan Y
Acta Pharmacol Sin; 2008 Aug; 29(8):990-7. PubMed ID: 18664332
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.
Kim JS; Kim MS; Park HJ; Jin SJ; Lee S; Hwang SJ
Int J Pharm; 2008 Jul; 359(1-2):211-9. PubMed ID: 18501538
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and bioequivalence testing of atorvastatin formulations in healthy male volunteers.
Mendoza L; Hajdúch M; Plausinaitis R; Platílová V; Emritte N; Svoboda M
Pharmazie; 2006 Sep; 61(9):805-6. PubMed ID: 17020163
[TBL] [Abstract][Full Text] [Related]
8. Improvement of bioavailability and photostability of amlodipine using redispersible dry emulsion.
Jang DJ; Jeong EJ; Lee HM; Kim BC; Lim SJ; Kim CK
Eur J Pharm Sci; 2006 Aug; 28(5):405-11. PubMed ID: 16777390
[TBL] [Abstract][Full Text] [Related]
9. Micronization of atorvastatin calcium by antisolvent precipitation process.
Zhang HX; Wang JX; Zhang ZB; Le Y; Shen ZG; Chen JF
Int J Pharm; 2009 Jun; 374(1-2):106-13. PubMed ID: 19446766
[TBL] [Abstract][Full Text] [Related]
10. Facile preparation of monodisperse pharmaceutical colloidal spheres of atorvastatin calcium via self-assembly.
Zhang HX; Zhao H; Wang JX; Chen JF; Lu YF; Yun J
Small; 2009 Aug; 5(16):1846-9. PubMed ID: 19415652
[No Abstract] [Full Text] [Related]
11. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
Cheng MB; Wang JC; Li YH; Liu XY; Zhang X; Chen DW; Zhou SF; Zhang Q
J Control Release; 2008 Jul; 129(1):41-8. PubMed ID: 18474405
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.
Khan FN; Dehghan MH
AAPS PharmSciTech; 2011 Dec; 12(4):1077-86. PubMed ID: 21879394
[TBL] [Abstract][Full Text] [Related]
13. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
Lv HX; Zhang ZH; Hui-Jiang ; Waddad AY; Zhou JP
Pharmazie; 2012 Jan; 67(1):46-53. PubMed ID: 22393830
[TBL] [Abstract][Full Text] [Related]
14. Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug.
Bandivadeka MM; Pancholi SS; Kaul-Ghanekar R; Choudhari A; Koppikar S
Drug Dev Ind Pharm; 2012 Jul; 38(7):883-92. PubMed ID: 22087760
[TBL] [Abstract][Full Text] [Related]
15. HPLC assay and pharmacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system.
Shen HR; Li ZD; Zhong MK
Pharmazie; 2006 Jan; 61(1):18-20. PubMed ID: 16454200
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats.
Anwar M; Warsi MH; Mallick N; Akhter S; Gahoi S; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
Eur J Pharm Sci; 2011 Oct; 44(3):241-9. PubMed ID: 21864678
[TBL] [Abstract][Full Text] [Related]
17. Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization.
Wei L; Li G; Yan YD; Pradhan R; Kim JO; Quan Q
Arch Pharm Res; 2012 Jun; 35(6):1037-43. PubMed ID: 22870813
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.
Wong SM; Kellaway IW; Murdan S
Int J Pharm; 2006 Jul; 317(1):61-8. PubMed ID: 16647232
[TBL] [Abstract][Full Text] [Related]
19. Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study.
Bandivadekar M; Pancholi S; Kaul-Ghanekar R; Choudhari A; Koppikar S
Drug Dev Ind Pharm; 2013 May; 39(5):696-703. PubMed ID: 22616839
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats.
Dong J; Yu X; Wang L; Sun YB; Chen XJ; Wang GJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1247-52. PubMed ID: 18817631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
